Cargando…
Vedolizumab-Induced Acute Interstitial Nephritis in Ulcerative Colitis
Vedolizumab is used in the treatment of inflammatory bowel disease and is generally well tolerated. We report a 20-year-old man who presented with right flank pain on a background of ulcerative colitis. He was on vedolizumab with his last dose 1 week before the onset of symptoms. Kidney function tes...
Autores principales: | Subhaharan, Deloshaan, Ramaswamy, Pradeep K., Francisco, Sewwandi, Ishaq, Naveed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232362/ https://www.ncbi.nlm.nih.gov/pubmed/35765681 http://dx.doi.org/10.14309/crj.0000000000000788 |
Ejemplares similares
-
Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adults
por: Subhaharan, Deloshaan, et al.
Publicado: (2023) -
Vedolizumab-associated diffuse interstitial lung disease in patients with ulcerative colitis: A case report
por: Zhang, Jie, et al.
Publicado: (2022) -
Inflammatory bowel disease patients have an increased risk of acute coronary syndrome: a systematic review and meta-analysis
por: Zaka, Ammar, et al.
Publicado: (2023) -
Mesalazine-Induced Interstitial Nephritis in a Patient With Ulcerative Colitis
por: da Cunha Marques, José, et al.
Publicado: (2022) -
Combination of vedolizumab and immunomodulators in ulcerative colitis
por: Pinton, P
Publicado: (2021)